AZ signs agreement for targeted drug delivery research
AstraZeneca and Aptamer Group will collaborate to leverage Aptamer’s platform for targeted delivery of oligonucelotides to the kidney for therapeutic development.
Archives for January 14, 2019
Pressure BioSciences launches contract service business for biopharma market
Pressure BioSciences has launched a commercial biopharmaceutical contract service business after acquiring a protein therapeutics platform that it says reduces challenges and manufacturing costs of the growing drug market.
Clinigen establishes ‘on-demand’ clinical trial supply chain
Clinigen’s newly announced business, Clinical Trial Service, will establish an on-demand supply chain for clinical trials and extends agreement with its partner Accord.
Thousand Oaks secures $45m to expand its CDMO, CMC service offerings
Thousand Oaks Biopharmaceuticals raised $45m in Series A financing, enabling the company to expand its CDMO and CMC services as well as its capabilities in global biologics development.
GSK expects ‘limits’ on Shingrix access in 2019
The company will hold off on advertising and expanding access to new countries until current demand is met.
Charles River offering AI-enabled drug discovery services via Atomwise tie-up
Charles River and Atomwise have formed a strategic alliance aimed at accelerating the drug discovery process using AI-powered design technology.
Lupin recalls 42 lots of antibiotic after contaminate found in vials
Lupin Pharmaceuticals voluntarily recalling lots of Ceftriaxone for Injection after rubber flecks were found in vials.